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0022±2836/97/430525±08 $25.00/0/mb9It has been shown that sequence-speci®c DNA-binding domains contain-
ing zinc ®ngers can be selected from libraries displayed on ®lamentous
bacteriophage. The af®nity and speci®city of these peptides are well
characterised in vitro, but few data are available to demonstrate speci®c
DNA binding and discrimination between closely related DNA sequences
in vivo. Transient transactivation assays were performed in mammalian
cells, using expression plasmids which produce different amounts of a
model transcription factor containing a phage-selected zinc ®nger DNA-
binding domain, and reporter plasmids which carry systematic variations
of the promoter sequence. When the intracellular concentration of the
transcription factor was appropriate, activation of gene expression was
absolutely dependent on a promoter having the same DNA sequence as
that originally used to select the zinc ®nger domain by phage display.
However, excessive intracellular concentrations of the transcription factor
resulted in some less-speci®c DNA binding, leading to gene activation
from similar promoters containing a maximum of two base changes.
Thus, provided delivery is carefully controlled, highly speci®c control of
gene expression in vivo can be achieved using arti®cial transcription fac-
tors containing phage-selected zinc ®nger DNA-binding domains.
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The differentiation and development of an
organism is effected by a programme of differential
gene expression which is ordered in space and
time; this is controlled mainly at the level of tran-
scription, by protein transcription factors which
bind to regulatory promoter DNA sequences
found adjacent to speci®c genes (Mitchell & Tjian,
1989; Nikolov & Burley, 1997; Ptashne & Gann,
1990; Roeder, 1991). Arti®cially manipulating this
programme would allow us to dissect develop-
mental pathways, and to interfere with the aetiol-
ogy of disease. Unfortunately, naturally occurring
transcription factors are not normally suitable for
applications where speci®c control over one gene
is required, because the DNA sequences they bind
are present in the promoters of many different
genes (Kel et al., 1995). In addition, gene regulation
by natural transcription factors often requires thephenicol acetyl
71339concerted action of combinations of factors, which
by themselves have little or no activity (Herschlag
& Johnson, 1993; Milos & Zaret, 1992; Reith et al.,
1994; Rivera et al., 1993).
One approach to the arti®cial control of gene
expression is to use transcription factors containing
potent activation or repression domains, and
engineered with new DNA-binding speci®cities for
rare binding sites associated only with the target
gene, but probably distinct from the natural pro-
moter. This strategy is feasible because transcrip-
tion factors are structurally modular, with different
domains responsible for DNA binding and tran-
scriptional regulation (Mitchell & Tjian, 1989; Pabo
& Sauer, 1992). These domains are often inter-
changeable such that chimaeric transcription fac-
tors with swapped characteristics can be easily
engineered (Brent & Ptashne, 1985).
The manipulation of the DNA-binding speci®city
of transcription factors is less straightforward.
Efforts in this ®eld have focused on the zinc ®nger
of the TFIIIA type: a small DNA-binding module
found in eukaryotic transcription factors (Klug &# 1997 Academic Press Limited
Figure 1. Amino acid sequence of the zinc ®nger DNA-binding domain ZN1, which was originally selected using the
nucleotide sequence GCGTGAGCG from a phage display library based on the three-®nger DNA-binding domain of
the protein Zif268. The three zinc ®ngers (F1, F2 and F3) are aligned, regions of secondary structure are marked
below the sequence, and key residue positions are numbered above the sequence relative to the ®rst amino acid in
the a-helix (residue 1). The selected residues which fall in the randomised portion of ®nger 2 are shown in italics.
Figure 2. Determination of the apparent Kd of ZN1 for
the optimally bound DNA sequence GCGTGAGCG by
full curve DNA-binding ELISA (&), contrasted to the
signal obtained using the binding site of wild-type
Zif268 (GCGTGGGCG) in the same assay (*).
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domains which bind to given DNA sequences
in vitro can be selected by bacteriophage display
(Choo & Klug, 1994a; Jamieson et al., 1994; Rebar
& Pabo, 1994; Greisman & Pabo, 1997; for a review
see Choo & Klug, 1995) and their speci®city later
assessed by screening for binding to 12 self-encod-
ing DNA oligonucleotide libraries (Choo & Klug,
1994b). The DNA-binding characteristics of some
phage-selected zinc ®ngers have been investigated
in vitro, con®rming that they function as well as
their naturally occurring counterparts (Choo &
Klug, 1994b; Jamieson et al., 1994; Rebar & Pabo,
1994). While the af®nity of such phage-selected
DNA-binding domains is quite high, usually fall-
ing in the nanomolar range for a three-®nger pep-
tide, the observed discrimination against closely
related DNA sequences, by a two to tenfold
increase in the apparent Kd per point mutation, is
rather modest.
Hence, here we have questioned whether DNA
binding by a phage-selected zinc ®nger domain is
suf®ciently discriminating to allow operations on
speci®c DNA sequences in vivo. We used a CAT
transactivation assay to investigate the ability of a
model phage-selected DNA-binding domain to dis-
criminate its target from a set of closely related
promoter sequences. We found that this was poss-
ible with a high degree of speci®city, but only
when the intracellular concentration of zinc ®nger
transcription factor was optimised. These results
warrant the use of phage-selected DNA-binding
domains to direct in vivo DNA manipulation, in
particular the control of gene expression, but
invoke the need for controlled delivery of the
DNA-binding domain in order to achieve speci®c
effects.
Results
In vitro DNA specificity of phage-selected
zinc fingers
A phage display library of the three-®nger
DNA-binding domain of Zif268 has been
described, in which ®ngers 1 and 3 have the wild-
type sequence but ®nger 2 is randomised in eight
positions which could function in DNA binding
(Choo & Klug, 1994a). Af®nity selections from thislibrary were previously performed using the nine
base-pair long Zif268 binding site, GCGTGGGCG,
in which the underlined three-base subsite con-
tacted by ®nger 2 was substituted by a different
triplet. Many selections yielded new DNA-binding
domains which bound to variants of the Zif268
binding site (Choo & Klug, 1994b).
One representative from these DNA-binding
domains was arbitrarily chosen for further speci-
®city experiments to be performed in vivo. This
domain, denoted ZN1 (Figure 1), was originally
selected against the sequence GCGTGAGCG (Choo
& Klug, 1994a), and the speci®city for the middle
triplet later con®rmed by the ``binding site signa-
ture'' method (Choo & Klug, 1994b). Zinc ®nger
phage displaying ZN1 bind to GCGTGAGCG with
an apparent Kd of 3nM (Figure 2). This value is
equal to the Kd for the complex of wild-type Zif268
and its optimised binding site GCGTGGGCG
(Christy & Nathans, 1989; Swirnoff & Milbrandt,
1995). The in vitro af®nity of ZN1 for DNA is there-
fore comparable to the wild-type Zif268, but the
clear preference for TGA is an improvement over
the wild-type Zif268 which is unable to discrimi-
nate strongly between TGG and GGG (Christy &
Nathans, 1989; Swirnoff & Milbrandt, 1995).
Figure 3. Activation of transcription by high-level
expression of transcription factor, acting on one copy of
a given binding site in the reporter plasmid. Schematic
representations of expression and reporter vectors are
shown above the histogram. Activation of transcription
is shown in the histogram as CAT activity, plotted as
the amount of chloramphenicol converted to the acetyl-
ated forms (cpm  104). The middle triplet of the DNA
binding site cloned into pMCAT3 (in one copy) is
shown below the diagram for each experiment.
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of transcription
The transient transactivation assay of Gorman
et al. (1982) is commonly used to detect the inter-
action of a DNA-binding protein with speci®c
DNA sequences in mammalian cells. Two plasmids
are typically cotransfected into mammalian cells.
One plasmid (the expression vector) produces a
transcription factor containing a DNA-binding
domain fused to an activation domain, while the
second plasmid (the reporter vector) carries a
speci®c DNA sequence of interest upstream of the
chloramphenicol acetyl transferase (CAT) reporter
gene and its minimal promoter (TATA box). Bind-
ing of the expressed transcription factor to the
DNA sequence of interest causes activation of the
CAT gene, which can be monitored by assaying
for enzyme activity.
To investigate the level of synthetic transcription
factor required for speci®c activation of gene
expression, we used two expression vectors which
produce different quantities of ZN1 fused to the
acidic transcription activation domain from VP16
(Fields, 1993) and an 11 amino acid epitope tag
derived from c-myc(Evan et al., 1985). The ®rst was
the pEF-BOS expression vector (Mizushima &
Shigezaku, 1990) which drives high-level
expression of the fusion protein from the strong
promoter of human elongation factor 1a (EF1a).
The second vector, pESP-SVTEXP (Shyam et al.,
1986), drives expression from the relatively weaker
SV40 promoter, resulting in lower intracellular
levels of the fusion protein (Mizushima &
Shigezaku, 1990). Western blotting of extracts con-
taining equal amounts of protein taken from cells
transfected with the two expression vectors reveals
that there is roughly a 15-fold difference in the
amount of transcription factor produced by the
respective expression vectors (data not shown).
The reporter vector used was pMCAT3, which
contains the metallothionein promoter region
upstream of the CAT gene (Luscher et al., 1989).
Binding sites cloned into the reporter plasmid were
of the generic sequence GCGXXXGCG, where the
underlined nucleotides corresponding to the sub-
site of the selected middle ®nger were varied. One
set of reporter vectors carried only one copy of
such a binding site, to test whether transcription
can be controlled by a single molecule of the arti®-
cial transcription factor bound to the promoter.
Another set of reporters which carried six consecu-
tive binding sites (thus amplifying the signal from
bound transcription factor) was used to detect
transcription resulting from low levels of non-
speci®c binding.
Transcription activation from a single
binding site
Figure 3 (see also Table 1) shows the CAT assay
result obtained in C3H10T1/2 cells, with the high-
level expression vector (pEF-BOS) and a reporterplasmid bearing one copy of the transcription fac-
tor binding site GCGTGAGCG. Cotransformation
of expression and reporter plasmids resulted in a
strong induction of CAT activity relative to con-
trols where the expression plasmid was cotrans-
fected with pMCAT3, or where pMCAT3 was
transfected alone. The result demonstrates that the
phage-selected zinc ®ngers are capable of binding
in vivo to the sequence used in their isolation by
in vitro methods. Furthermore, when incorporated
into engineered transcription factors this binding
directs the downstream events which cause tran-
scriptional activation of target genes. To test the
speci®city of transcription activation, the exper-
iment was repeated using reporters with single
copy binding sites containing the middle triplets
TAA, GAT or TAT, which gave no signi®cant
increase over the background level of CAT
expression (Table 1). Therefore, one copy of a
Table 1. The absolute values plotted in Figures 3, 4
and 5








nonea 0.029 0.071 0.036
noneb 0.034 0.058 0.029
TGA 9.767 44.947* 10.537
CGA ND 7.563 0.023
GGA ND 7.842 0.031
AGA ND 11.921 0.079
TCA ND 10.623 0.025
TTA ND 4.924 0.020
TAA 0.043 5.238 0.026
TGC ND 5.041 0.035
TGT ND 12.412 0.082
TGG ND 5.217 0.037
GAA ND 3.248 0.034
GCA ND 3.456 0.024
GTA ND 0.123 0.023
TAT 0.033 2.989 0.027
GTG ND 0.087 0.038
GTC ND 0.024 0.037
GTT ND 0.073 0.024
GAT 0.036 0.104 0.022
Values correspond to the amount of [14C]chloramphenicol con-
verted by a ®xed amount of cell extract following induction of
CAT activity using a given combination of expression and
reporter plasmids. These vector combinations are given above
the three right-hand columns, which list the amount of conver-
sion in cpm (104), while the ®rst column lists the middle tri-
plets inserted into the generic binding site GCGXXXGCG
present (in one or six copies) in the promoter of the reporter
plasmid. Also given are values for two controls corresponding
to the use of pMCAT3 without a binding site for the zinc ®n-
gers, transfected into cells alone (nonea), or together with the
appropriate expression vector for each experiment (noneb).
Converted chloramphenicol was measured while the CAT
assay was in the linear range, except for that value marked
with an asterisk, in which the enzyme activity is therefore
likely to be somewhat underestimated.
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an upstream promoter can regulate speci®c gene
expression.
Effect of DNA-binding protein concentration on
specificity in vivo
CAT assays using one copy of the zinc ®nger
binding site suggest either that mutant sequences
do not interact appreciably with ZN1, or that weak
binding does not result in measurable transcrip-
tional activation. To examine the DNA-binding
speci®city of ZN1 in greater detail, the transactiva-
tion assay was made more sensitive by using
reporter plasmids which contain six copies of the
same binding site upstream of the CAT gene.
Figure 4 (see also Table 1) shows that using the
high-level expression vector (pEF-BOS) and a
reporter bearing six copies of the sequence
GCGTGAGCG, an even greater increase in the
level of CAT expression was obtained. Sequence-
speci®city was investigated using nine other such
reporter constructs which systematically encom-
pass the possible single base-pair deviations fromthe optimal triplet TGA, and a small number of
additional reporters in which the binding sites con-
tained two base changes or completely different
middle triplets. In these cases, signi®cant activation
of transcription can be detected from promoters
with one, or even two, base deviations from the
optimal 9 bp sequence. The mutations caused
cumulative decreases in transcriptional activation
in that promoters with only a single base change
were capable of stronger activation than those with
two base changes, while no CAT activation was
observed from promoters with three base changes
(Figure 4). The data shown in Table 1 and Figure 4
were derived from transfections of C3H10T1/2
cells, but similar data (not shown) were obtained
in COS1 cells, meaning that the results are not par-
ticular to the use of any one cell line. Thus, in con-
trast to the activation studies performed using one
copy of the zinc ®nger binding site as a promoter,
multiply repeated promoters reveal degrees of
non-speci®c occupancy of closely related binding
sites in the presence of high concentrations of
DNA-binding domain.
Non-speci®c binding of proteins to DNA can be
reduced by limiting the concentration of the reac-
tants to the Kd value for the speci®c reaction.
Accordingly, the observed activation of gene
expression from non-speci®c promoters might be
eliminated by reducing the intracellular concen-
tration of arti®cial transcription factor. The exper-
iment of Figure 4 was therefore repeated using the
vector pESP-SVTEXP to drive low-level expression
of ZN1. Figure 5 shows that under these con-
ditions, activation is reduced but occurs only from
GCGTGAGCG: any deviations from this sequence
completely suppress CAT expression. Hence limit-
ing the level of the arti®cial transcription factor in
the cell reduces binding to non-speci®c DNA
sequences, abolishing transcription activation from
mutant promoters.
Discussion
Promoter-speci®c activation of gene expression
has been described in cell culture, using a represen-
tative phage-selected DNA-binding domain which
was converted to a transcription factor by fusion
with the activation domain from VP16. Signi®cant
activation of gene expression was recorded by the
CAT assay when one binding site for the arti®cial
transcription factor was present upstream of the
reporter gene, and under these circumstances no
non-speci®c activation of gene expression was
detected from a limited set of promoters. However,
a degree of non-speci®c activation of gene
expression was seen when the assay was made
more sensitive by using promoters with multiple
binding sites containing a series of systematic
mutations. With six binding sites, substantial acti-
vation of transcription was noted from promoters
which carried point mutations. All-or-none acti-
vation particular to the correct promoter could
Figure 4. Activation of transcription by high-level expression of transcription factor, acting on six tandem copies of a
given binding site in the reporter plasmid. Schematic representations of expression and reporter vectors are shown in
the top right corner. Activation of transcription is shown in the histogram as CAT activity, plotted as the amount of
chloramphenicol converted to the acetylated forms (cpm  104). The middle triplet of the six DNA binding sites
cloned into pMCAT3 is shown below the plot for each experiment. Blocks of triplets corresponding to one, two and
three nucleotide deviations from the optimal triplet (TGA) are marked below the diagram. In general these deviations
cause cumulative decreases in the level of transcriptional activation according to the number of mutations.
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tration of transcription factor was reduced to an
appropriate level by the use of a less potent
expression vector.
The results show that it is possible to induce
gene expression in vivo from speci®c promoters
using phage-selected zinc ®ngers fused to tran-
scriptional activation domains. The ability of the
engineered transcription factor to activate tran-
scription from closely related promoters correlated
well with its in vitro DNA-binding speci®city. On
the contrary, the function in vivo of many naturally
occurring transcription factors (including homeo-
domains (Hayashi & Scott, 1990), basic region leu-
cine zipper proteins (Lamb & McKnight, 1991) and
the prototype Gal4 transcription factor (Vashee
et al., 1993)) cannot be accounted for merely by
their in vitro DNA-binding preferences, probably
because they often require additional proteins to
form the complexes which regulate gene
expression. Thus while the actions of natural tran-
scription factors are unpredictable a priori, those of
arti®cial factors are a simple extension of their
well-established in vitro DNA-binding character-
istics. Hence it follows that transcription factors
such as those we have described are preferable tonatural factors for the arti®cial control of gene
expression.
Even so, the speci®city of transcriptional control
clearly depends on the intracellular concentration
of transcription factor. According to the law of
mass action, high transcription factor concentration
favours promoter binding, leading to stronger acti-
vation, but at the same time increases binding to
closely related DNA sequences. Excessive intra-
cellular concentrations of protein can therefore
result in a loss of DNA-binding speci®city and
aberrant gene activation. Our results re¯ect this
and highlight the necessity for ®ne tuning of the
transcription factor concentration such that only
speci®c complexes are formed in vivo. In appli-
cations of arti®cial gene regulation this can be
achieved using appropriate expression vectors, as
here, or by means of alternative delivery protocols
which attain the right balance between maximal
activation of the target gene and a minimum effect
on other genes.
Differential regulation of very similar promoters
by proteins containing phage-selected zinc ®ngers
has been demonstrated above. In the CAT assay
system used, where the only variable in each
experiment is the 9 bp sequence of the zinc ®nger
Figure 5. Activation of transcription by low-level expression of transcription factor, acting on six tandem copies of a
given binding site present in the reporter plasmid. Schematic representations of expression and reporter vectors are
shown in the top right corner. Activation of transcription is shown in the histogram as CAT activity, plotted as the
amount of chloramphenicol converted to the acetylated forms (cpm  104). The middle triplet of the six DNA binding
sites cloned into pMCAT3 is shown below the plot for each experiment. It can be seen that any deviations from the
optimal promoter sequence abolish transcriptional activation.
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indicate highly speci®c protein-DNA interactions
in vivo. This raises the possiblility of using zinc ®n-
gers to discriminate between normal and point-
mutated DNA, for example cellular proto-onco-
genes and transforming mutants which differ by a
single base-pair. A referee has made the valid
point that a useful next step might be to ascertain
whether the highly speci®c interactions we have
noted using the transient activation assay can be
reproduced in cells where the reporters are stably
integrated in chromosomes. Although such data
are not yet available, we have previously shown
that a designed zinc ®nger protein can inhibit the
expression of a stably integrated fusion oncogene
expressed in a mouse cell line (Choo et al., 1994).
An issue related to the speci®city of DNA bind-
ing in vivo is the length of the target binding site.
At present, zinc ®nger design has been based on
three-®nger domains which directly contact at
most ten base-pairs (Elrod-Erickson et al., 1996;
Isalan et al., 1997; Swirnoff & Milbrandt, 1995).
While binding sites of this length would normally
be suf®cient to specify a unique locus within any
given gene, a complex genome would be predicted
to contain thousands of identical binding sites.
Hence to target a unique DNA site in the genome
would require a DNA-binding domain which spe-
ci®es 13 to 16 base-pairs, i.e. containing four or ®ve
zinc ®ngers. However, while longer arrays of zinc®ngers might bind to rarer binding sites, the dis-
crimination against any mutations in those sites
might be expected to be relatively weaker. As with
the intracellular concentration of transcription fac-
tor, which must be limited to a ``window'' which
allows for speci®c high-level transcriptional acti-
vation, a compromise will probably be required
between the need to bind long stretches of DNA
and to discriminate strongly between similar
sequences, which in practice will depend on the
application.
Materials and methods
In vitro DNA-binding assays
Zinc ®nger phage selections and binding site signa-
tures were performed as described (Choo & Klug, 1994
a,b). The method for the calculation of apparent Kd for
ZN1 was exactly as described by Choo & Klug (1994b).
Eukaryotic expression constructs
Genes to be cloned into expression plasmids were gen-
erated by the polymerase chain reaction (PCR) using
phage DNA as the template. PCR primers included
appropriate initiation and termination codons and
restriction sites for cloning. Expression constructs were
generated by inserting in-frame fusions between the acti-
vation domain of herpes simplex virus VP16 (Fields,
1993) and zinc ®ngers into the NotI site of pEF-BOS
In vivo Action of Phage-selected Zinc Fingers 531(Mizushima & Shigezaku, 1990), or between the HindIII
and XhoI sites of pESP-SVTEXP (Shyam et al., 1986).
Reporter plasmids
The reporter plasmids were constructed by inserting
one or six copies of the target sequence into the unique
BglII site of the reporter vector pMCAT3 (Luscher et al.,
1989). Reporter plasmids with one copy of the target
sequence were as follows: p1MCAT3-ST1 (50-
GCGTGAGCG-30), p1MCAT3-2 (50-GCGTAAGCG-30),
p1MCAT3-ST2 (50-GCGGATGCG-30) and p1MCAT3-
MST2 (50-GCGTATGCG-30). Reporter plasmids contain-
ing six tandem copies of the target sequence were:
pMCAT3-ST1 (50-GCGTGAGCG-30), pMCAT3-6 (50-
GCGCGAGCG-30), pMCAT3-7 (50-GCGGGAGCG-30),
pMCAT3-8 (50-GCGAGAGCG-30), pMCAT3-1 (50-GCG-
TCAGCG-30), pMCAT3-MST1 (50-GCGTTAGCG-30),
pMCAT3-2 (50-GCGTAAGCG-30), pMCAT3-3 (50-
GCGTGCGCG-30), pMCAT3-4 (50-GCGTGTGCG-30),
pMCAT3-5 (50-GCGTGGGCG-30), pMCAT3-13 (50-
GCGGAAGCG-30), pMCAT3-14 (50-GCGGCAGCG-30),
pMCAT3-9 (50-GCGGTAGCG-30), pMCAT3-MST2 (50-
GCGTATGCG-30), pMCAT3-10 (50-GCGGTGGCG-30),
pMCAT3-11 (50-GCGGTCGCG-30), pMCAT3-12 (50-
GCGGTTGCG-30) and pMCAT3-ST2 (50-GCGGATGCG-
30).
CAT transactivation assays
C3H10T1/2 and COS1 cells were maintained in
Dulbecco's modi®ed Eagle's medium (DMEM) sup-
plemented with 5% (v/v) foetal bovine serum (FBS),
penicillin G (100 units/ml) and streptomycin sulphate
(100 mg/ml). C3H10T1/2 and COS1 cells were transi-
ently co-transfected with 10 mg of the reporter plasmid
and 10 mg of the expression vector. The DNA used in
transfections was prepared by the standard alkaline lysis
method. Cells were trypsinized and plated at 2  105
cells per 100 mm diameter plate; on the following day,
cells were supplied with fresh medium, and three hours
later calcium phosphate-DNA coprecipitates (1 ml per
100 mm dish) were added. Following 16 to 18 hours, the
precipitates were removed, the cells were washed twice
in PBS and given complete medium. After 48 hours, the
cells were harvested for CAT and luciferase assays as
described (de Wet et al., 1987; Gorman et al., 1982). The
vector RSVL (de Wet et al., 1987), which contains the
Rous sarcoma virus long terminal repeat linked to luci-
ferase, was used as an internal control to normalize for
differences in transfection ef®ciency.
All assays were performed as duplicate independent
transfections. Equivalent amounts of protein (15 to 25 mg
as determined with the Bio-Rad protein kit and bovine
serum albumin as a standard) were used in each CAT
conversion reaction, which proceeded for one hour such
that values were within the linear range of the assay.
Relative CAT activities were determined by quantifying
the amounts of [14C]chloramphenicol present in spots
corresponding to the two acetylated species cut out from
the thin layer chromatographs. Plasmid pG5EC (which
has ®ve consensus 17-mer GAL4-binding sites upstream
from the minimal promoter of the adenovirus E1b TATA
box) and pM1VP16 vector (which encodes an in-frame
fusion between the DNA-binding domain of GAL4 and
the activation domain of herpes simplex virus VP16)
were used as a positive control of the transient co-trans-
fection assays (Sadowski et al., 1992).Acknowledgements
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